The UCI Health Chao Family Comprehensive Cancer has launched a first-in-the-nation clinical trial combining two recently approved drugs to prevent recurrence of adult acute myeloid leukemia (AML) in patients with myelodysplastic changes or therapy-related AML. The investigator-initiated clinical trail led by oncologist Dr. Deepa Jeyakumar is adding the stem-cell drug…
UC San Diego researchers recruiting participants, ages 7 to 14, to determine whether cannabidiol, an extract of cannabis, can reduce behavioral symptoms of severe autism spectrum disorder
UC San Diego Health is ranked first in San Diego and sixth in California, placing it among the nation’s best hospitals, according to the 2020-2021 U.S. News & World Report. Eight common procedures and conditions were also rated “high performing.”
Used as a noninvasive diagnostic tool, it might help patients with common nonalcoholic fatty liver disease avoid one of its deadly, progressive complications
In Phase II trial, treatment inhibited key enzyme, resulting in lowered triglyceride production and slower progression of non-alcoholic fatty liver disease to its more dangerous form: non-alcoholic steatohepatitis
Launched in 2002, the Vietnam Era Twin Study of Aging will continue to follow and document risk and protective factor for cognitive and brain aging in 1,600 male twins
Deleting an inhibitory gene in natural killer cells derived from induced pluripotent stem cells is found to boost their anti-tumor activity and persistence; researchers now seek to develop a clinical therapy
